The Orphan Drug Act Revisited

JAMA. 2019 Mar 5;321(9):833-834. doi: 10.1001/jama.2019.0290.

Authors

Shailin Thomas^{1

2}, Arthur Caplan³

Affiliations

¹ New York University School of Medicine, New York.
² Harvard Law School, Cambridge, Massachusetts.
³ Division of Medical Ethics, NYU Langone Medical Center, New York, New York.

PMID: 30768155
DOI: 10.1001/jama.2019.0290

No abstract available

MeSH terms

Drug Approval / legislation & jurisprudence*
Drug Costs
Drug Industry / economics
Drug Industry / legislation & jurisprudence*
Humans
Legislation, Drug*
Orphan Drug Production / economics
Orphan Drug Production / legislation & jurisprudence*
Precision Medicine
Rare Diseases / drug therapy*
United States
United States Food and Drug Administration